Amphastar Pharmaceuticals, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2014 | $107.5M | $389.4M | $67.8M |
| FY2015 | $94.6M | $390.1M | $66.1M |
| FY2016 | $98.5M | $427.7M | $72.4M |
| FY2017 | $117.3M | $451.1M | $65.6M |
| FY2018 | $149.2M | $513.6M | $86.3M |
| FY2019 | $159.4M | $587.0M | $73.7M |
| FY2020 | $182.5M | $631.2M | $92.6M |
| FY2021 | $226.0M | $671.5M | $126.4M |
| FY2022 | $213.3M | $742.0M | $156.1M |
| FY2023 | $873.5M | $1.51B | $144.3M |